Progesterone for some preterm preeclampsia pregnancies
Part of Women’s health & pregnancy clinical trials.
This trial tests whether taking progesterone can improve outcomes for people with preeclampsia that is being managed without immediate delivery. It’s meant for pregnancies in a specific gestational age window and when both mother and baby are stable enough for “expectant management.”
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently between 23 weeks 0 days and 34 weeks 0 days pregnant when you first join
- Your pregnancy has preeclampsia that is being monitored and managed without urgent delivery (expectantly managed)
- You are able and willing to understand the study and sign informed consent
- You are not beyond 33 weeks pregnant when you join
- You do not need emergency delivery right now due to serious mother complications (like bleeding from placental abruption, breathing fluid buildup in lungs, or very severe clotting problems)
- You do not have urgent baby distress symptoms that would require immediate delivery (such as concerning fetal heart rate patterns or no fetal heart rate variability)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether dipyridamole, a medicine that helps improve blood flow, can help manage early-onset preeclampsia and potentially prolong the pregnancy safely. It aims to see if the drug is feasible, how it works in the body, and if it has beneficial effects for both mother and baby.
This trial studies whether extra screening in the first trimester for preeclampsia (dangerous blood pressure problems in pregnancy) can reduce health problems for both the mother and baby. You may be offered a screening plan that helps identify risk earlier so care can be adjusted.
This study aims to see if a new blood test can help predict preeclampsia, a serious condition that can occur during pregnancy. It may help identify risk early so that you and your baby can receive the right care.
This study collects blood samples and routine pregnancy data to improve early detection of preeclampsia (a serious pregnancy complication). It aims to build a biobank for future research, and you can participate if you are in your first trimester with a single baby.
This trial tests if taking pravastatin (a statin) can improve blood flow to the placenta in pregnant people with either severe early-onset preeclampsia (high blood pressure) or a baby not growing well. The goal is to help the pregnancy last longer and improve outcomes.
This study looks at blood vessel function in pregnant people with preeclampsia to see if it can help predict outcomes. It involves non-invasive measures and routine blood tests.
Hear when a new Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.